chr1-13780865-T-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001393986.1(PRDM2):​c.3070T>A​(p.Ser1024Thr) variant causes a missense change. The variant allele was found at a frequency of 0.0413 in 1,610,400 control chromosomes in the GnomAD database, including 1,547 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.031 ( 116 hom., cov: 30)
Exomes 𝑓: 0.042 ( 1431 hom. )

Consequence

PRDM2
NM_001393986.1 missense

Scores

6
12

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 6.47

Publications

9 publications found
Variant links:
Genes affected
PRDM2 (HGNC:9347): (PR/SET domain 2) This tumor suppressor gene is a member of a nuclear histone/protein methyltransferase superfamily. It encodes a zinc finger protein that can bind to retinoblastoma protein, estrogen receptor, and the TPA-responsive element (MTE) of the heme-oxygenase-1 gene. Although the functions of this protein have not been fully characterized, it may (1) play a role in transcriptional regulation during neuronal differentiation and pathogenesis of retinoblastoma, (2) act as a transcriptional activator of the heme-oxygenase-1 gene, and (3) be a specific effector of estrogen action. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.00453192).
BP6
Variant 1-13780865-T-A is Benign according to our data. Variant chr1-13780865-T-A is described in ClinVar as Likely_benign. ClinVar VariationId is 403342.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0312 (4710/150756) while in subpopulation NFE AF = 0.0467 (3166/67732). AF 95% confidence interval is 0.0454. There are 116 homozygotes in GnomAd4. There are 2255 alleles in the male GnomAd4 subpopulation. Median coverage is 30. This position passed quality control check.
BS2
High AC in GnomAd4 at 4710 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PRDM2NM_001393986.1 linkc.3070T>A p.Ser1024Thr missense_variant Exon 8 of 10 ENST00000311066.10 NP_001380915.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PRDM2ENST00000311066.10 linkc.3070T>A p.Ser1024Thr missense_variant Exon 8 of 10 5 NM_001393986.1 ENSP00000312352.6 Q13029-1

Frequencies

GnomAD3 genomes
AF:
0.0313
AC:
4708
AN:
150640
Hom.:
116
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.00847
Gnomad AMI
AF:
0.00549
Gnomad AMR
AF:
0.0348
Gnomad ASJ
AF:
0.0470
Gnomad EAS
AF:
0.000588
Gnomad SAS
AF:
0.0360
Gnomad FIN
AF:
0.0241
Gnomad MID
AF:
0.0224
Gnomad NFE
AF:
0.0468
Gnomad OTH
AF:
0.0336
GnomAD2 exomes
AF:
0.0346
AC:
8686
AN:
251014
AF XY:
0.0366
show subpopulations
Gnomad AFR exome
AF:
0.00744
Gnomad AMR exome
AF:
0.0225
Gnomad ASJ exome
AF:
0.0461
Gnomad EAS exome
AF:
0.000163
Gnomad FIN exome
AF:
0.0266
Gnomad NFE exome
AF:
0.0470
Gnomad OTH exome
AF:
0.0403
GnomAD4 exome
AF:
0.0423
AC:
61765
AN:
1459644
Hom.:
1431
Cov.:
53
AF XY:
0.0421
AC XY:
30559
AN XY:
726252
show subpopulations
African (AFR)
AF:
0.00703
AC:
235
AN:
33438
American (AMR)
AF:
0.0232
AC:
1038
AN:
44706
Ashkenazi Jewish (ASJ)
AF:
0.0445
AC:
1163
AN:
26110
East Asian (EAS)
AF:
0.000101
AC:
4
AN:
39692
South Asian (SAS)
AF:
0.0394
AC:
3397
AN:
86164
European-Finnish (FIN)
AF:
0.0274
AC:
1466
AN:
53412
Middle Eastern (MID)
AF:
0.0475
AC:
274
AN:
5764
European-Non Finnish (NFE)
AF:
0.0466
AC:
51783
AN:
1110076
Other (OTH)
AF:
0.0399
AC:
2405
AN:
60282
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
3573
7146
10720
14293
17866
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1912
3824
5736
7648
9560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0312
AC:
4710
AN:
150756
Hom.:
116
Cov.:
30
AF XY:
0.0307
AC XY:
2255
AN XY:
73570
show subpopulations
African (AFR)
AF:
0.00845
AC:
346
AN:
40956
American (AMR)
AF:
0.0348
AC:
527
AN:
15146
Ashkenazi Jewish (ASJ)
AF:
0.0470
AC:
163
AN:
3466
East Asian (EAS)
AF:
0.000590
AC:
3
AN:
5086
South Asian (SAS)
AF:
0.0365
AC:
172
AN:
4712
European-Finnish (FIN)
AF:
0.0241
AC:
250
AN:
10352
Middle Eastern (MID)
AF:
0.0276
AC:
8
AN:
290
European-Non Finnish (NFE)
AF:
0.0467
AC:
3166
AN:
67732
Other (OTH)
AF:
0.0332
AC:
70
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
206
412
617
823
1029
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
58
116
174
232
290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0434
Hom.:
127
Bravo
AF:
0.0303
TwinsUK
AF:
0.0520
AC:
193
ALSPAC
AF:
0.0402
AC:
155
ESP6500AA
AF:
0.00749
AC:
33
ESP6500EA
AF:
0.0451
AC:
388
ExAC
AF:
0.0351
AC:
4258
Asia WGS
AF:
0.0140
AC:
50
AN:
3478
EpiCase
AF:
0.0486
EpiControl
AF:
0.0470

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.28
BayesDel_addAF
Benign
-0.52
T
BayesDel_noAF
Benign
-0.49
CADD
Uncertain
23
DANN
Benign
0.95
DEOGEN2
Benign
0.084
.;T;.;.
Eigen
Uncertain
0.23
Eigen_PC
Uncertain
0.30
FATHMM_MKL
Uncertain
0.91
D
LIST_S2
Benign
0.85
D;D;.;T
MetaRNN
Benign
0.0045
T;T;T;T
MetaSVM
Benign
-0.74
T
MutationAssessor
Uncertain
2.4
M;M;.;.
PhyloP100
6.5
PrimateAI
Uncertain
0.59
T
PROVEAN
Benign
-0.87
N;N;N;N
REVEL
Benign
0.17
Sift
Uncertain
0.0030
D;D;D;D
Sift4G
Benign
0.089
T;T;T;T
Polyphen
0.86
P;P;.;.
Vest4
0.24
MPC
0.17
ClinPred
0.033
T
GERP RS
6.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.26
gMVP
0.47
Mutation Taster
=94/6
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41269807; hg19: chr1-14107360; COSMIC: COSV52446694; COSMIC: COSV52446694; API